Phase II Study of Doxorubicin and Avastin® in Sarcoma.

NCT00755261 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped The study has been terminated due to low accrual.

Conditions

Sarcoma
Soft Tissue Sarcoma

Interventions

DRUG: Avastin
DRUG: Doxorubicin

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins